PHYTOCHEMICAL SCREENING AND TOXICITY TEST OF MANGROVE LEAF ETHANOL EXTRACT (Bruguiera gymnorrhiza) WITH BRINE SHRIMP LETHALITY TEST (BSLT) METHOD

Authors

  • Friyan Criscanus Manopo sam Ratulangi University
  • Fatimawali Fatimawali
  • Olvie Datu

DOI:

https://doi.org/10.35799/pha.12.2023.42848

Keywords:

Skrining Fitokimia, Brine Shirmp Lethality Test, Bruguiera gymnorrhiza

Abstract

Cancer is one of the biggest causes of death in the world. Therefore, efforts to manufacture drugs for cancer treatment continue to be developed. One of the efforts to develop cancer drugs is by using medicinal plants which are empirically used by local communities in various regions. This study aims to analyze the content of secondary metabolites contained in the leaf extract of the Mangrove Bruguiera gymnorrhiza and to determine the potential as an anticancer by determining the LC50 value. The extract was obtained by maceration using 96% ethanol solvent, identification of secondary metabolites by phytochemical screening and to determine the anticancer potential using the BSLT method with data analysis using Microsoft Excel. The phytochemical test results showed that the leaf extract contained alkaloids, flavonoids, saponins, tannins, and did not contain steroid/triterpenoid compounds. The results of the analysis showed that the ethanol extract of mangrove leaf (Bruguiera gymnorrhiza) was highly toxic with an LC50 value of 24.1 µg/ml.

 

Downloads

Published

2023-03-09

How to Cite

Manopo, F. C., Fatimawali, F., & Datu, O. (2023). PHYTOCHEMICAL SCREENING AND TOXICITY TEST OF MANGROVE LEAF ETHANOL EXTRACT (Bruguiera gymnorrhiza) WITH BRINE SHRIMP LETHALITY TEST (BSLT) METHOD. PHARMACON, 12(1), 83–91. https://doi.org/10.35799/pha.12.2023.42848

Issue

Vol. 12 No. 1 (2023): PHARMACON

Section

Articles

License

Copyright (c) 2023 PHARMACON

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)